Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Understanding the effects of ADHD in Children with Dr. Daniel Amen

The health of the human brain is of utmost importance considering it is responsible for how we move, the ways in which we give and interpret information, our memories, our moods and behavior and so much more. It is also why when the brain is dealing with disorders that affect normal activities it can be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The health of the human brain is of utmost importance considering it is responsible for how we move, the ways in which we give and interpret information, our memories, our moods and behavior and so much more. It is also why when the brain is dealing with disorders that affect normal activities it can be a detriment to how someone functions. One of those disorders is ADHD, or Attention-Deficit/Hyperactivity Disorder, which is normally discovered in children who exhibit signs that they are unable to stay focused and control their impulses, and several other symptoms, according to the CDC.

ADHD affects about six million children between the ages of three and 17 years old, says the CDC, and educating children with ADHD comes with a different approach that requires some consideration to that.

To discuss the nature of ADHD, how it affects children and adults, and the ways it affects how children are taught, entrepreneur, CEO, author and speaker, Dr. Daniel Amen, spoke to Dustin Odham about the realities of ADHD on the newest episode of “Change Starts Here.”

Odham and Amen further talked about …

  1. Defining ADHD and how it affects the brain
  2. The primary symptoms of ADHD and how its identified
  3. How ADHD can impact someone’s life if the disorder is left untreated

Citing a Harvard study which found that when the disorder was overlooked in people they had higher instances of substance abuse, Dr. Amen said that untreated ADHD has very negative effects.

“When left untreated it has serious consequences,” he said. “Fifty-two percent of people with untreated ADD abuse substances, there’s a higher incidence of divorce, bankruptcy, incarceration, job loss, school failure, and that’s just not okay … it can devastate people’s lives,” said Dr. Amen.

Dr. Daniel Amen is an entrepreneur, CEO, best-selling author and speaker. He is the founder of Amen Clinics and is a nationally well-known physician and psychiatrist. He’s treated over 20,000 people with ADHD throughout his career and is a graduate of Oral Roberts University.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512